Clinical trial
Evaluation of Directional Recording and Stimulation Using the spiderSTN During the Implantation of DBS Leads
NCT02894567 is registered in ClinicalTrials.gov with Aleva Neurotherapeutics SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Directional Recording and Stimulation Using the spiderSTN During the Implantation of DBS Leads
- Lead sponsor
- Aleva Neurotherapeutics SA
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- September 30, 2016
- Completion date
- February 28, 2017
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
essential tremor, parkinson's disease